ANEB logo

Anebulo Pharmaceuticals, Inc. (ANEB)

Profile

Full Name

Anebulo Pharmaceuticals, Inc.

Ticker

NASDAQ: ANEB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 7, 2021

Indexes

Not included

Website

http://www.anebulo.com

Employees

2

Key Details

Price

$3.10(-1.27%)

Market cap

$127.36M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.32(+31.91% YoY)

PE ratio

-

Next earnings date

Sep 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.10
    ANEB price is $3.10

    30-Day Relative Volume

    0.82
    ANEB 30-day relative volume is 0.82

    Price Performance

    Price Today change

    -1.27%
    ANEB price is down -1.27% today

    Price YTD change

    +84.52%
    ANEB price is up +84.52% since January 1st

    Price 1-year change

    +40.91%
    ANEB price is up +40.91% year-on-year

    Price 3-year change

    +3.85%
    ANEB price is up +3.85% over the past 3 years

    Price Range

    Price All-time high

    $9.33
    ANEB price is currently -66.77% below its historical high of $9.33

    Price 3-year low

    $0.80
    ANEB price is currently +287.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $127.36M
    ANEB market capitalization is $127.36 million

    Market cap 3-year change

    +82.77%
    ANEB market capitalization is up +82.77% over the past 3 years

    Market cap All-time high

    $208.23M
    ANEB market capitalization is currently -38.84% below its historical high of $208.23 million

    Market cap sector rank

    46.25%
    ANEB market capitalization is higher than 46.25% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +58.43%
    ANEB shares outstanding is up +58.43% year-on-year

    Shares Outstanding 3-Year Change

    +75.99%
    ANEB shares outstanding is up +75.99% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.62
    ANEB beta is 0.62

    200-day SMA

    $1.46
    ANEB price is currently +111.66% above its 200-day simple moving average

    50-day SMA

    $1.53
    ANEB price is currently +102.87% above its 50-day simple moving average

    RSI

    80.81
    ANEB 14-day relative strength index is 80.81

    Volume

    0.82
    ANEB 30-day relative volume is 0.82

    ATR

    $0.24
    ANEB average true range is $0.24

    10-day Historical Volatility

    411.38%
    ANEB 10-day historical volatility is 411.38%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ANEB annual revenue value is unknown

    Revenue Analysts estimate

    -
    ANEB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ANEB annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ANEB annual revenue is unknown

    EPS

    EPS

    -$0.32
    ANEB annual earnings per share is -$0.32

    EPS Analysts estimate

    -$0.25
    ANEB annual earnings per share is currently +28.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +31.91%
    ANEB annual earnings per share is up +31.91% year-on-year

    EPS Sector rank

    72.18%
    ANEB annual earnings per share is higher than 72.18% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ANEB annual gross profit value is unknown

    Gross margin

    -
    ANEB annual gross profit margin value is unknown

    Operating profit

    -$8.31M
    ANEB annual operating income is -$8.31 million

    Operating margin

    -
    ANEB annual operating profit margin value is unknown

    Net income

    -$8.20M
    ANEB annual net profit is -$8.20 million

    Net margin

    -
    ANEB annual net profit margin value is unknown

    Expenses

    Total expenses

    $8.31M
    ANEB annual total expenses is $8.31 million

    Operating expenses

    $8.31M
    ANEB annual total operating expenses is $8.31 million

    Cost of goods sold

    -
    ANEB annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $4.76M
    ANEB annual SGA is $4.76 million

    Depreciation and amortization

    -
    ANEB annual depreciation & amortization value is unknown

    Interest expense

    $151.20K
    ANEB annual interest expense is $151.20 thousand

    Income tax

    -
    ANEB annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$8.05M
    ANEB annual earnings before interest & taxes is -$8.05 million

    EBITDA

    -$8.05M
    ANEB annual EBITDA is -$8.05 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.07M
    ANEB annual total assets is $4.07 million

    Non current assets

    $565.10K
    ANEB annual long term assets is $565.10 thousand

    Current assets

    $3.51M
    ANEB annual total current assets is $3.51 million

    Cash and cash equivalents

    $3.09M
    ANEB annual cash & cash equivalents is $3.09 million

    Accounts receivable

    -
    ANEB annual accounts receivable value is unknown

    Inventory

    -
    ANEB annual inventory value is unknown

    Liabilities

    Total liabilities

    $260.60K
    ANEB annual total liabilities is $260.60 thousand

    Long term liabilities

    $0.00
    ANEB annual total long term liabilities is $0.00

    Current liabilities

    $260.60K
    ANEB annual total current liabilities is $260.60 thousand

    Accounts payable

    $156.40K
    ANEB annual accounts payable is $156.40 thousand

    Debt

    Total debt

    $0.00
    ANEB annual total debt is $0.00

    Total debt 1-year change

    0%
    ANEB annual total debt has remained unchanged year-on-year

    Long term debt

    -
    ANEB annual long term debt value is unknown

    Short term debt

    -
    ANEB annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $3.81M
    ANEB annual stockholders equity is $3.81 million

    Book value

    $3.81M
    ANEB annual book value is $3.81 million

    Retained earnings

    -$65.40M
    ANEB annual retained earnings is -$65.40 million

    Working capital

    $3.25M
    ANEB annual working capital is $3.25 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$8.09M
    ANEB annual cash flow from operations is -$8.09 million

    Cash from operations 1-year change

    +16.44%
    ANEB annual cash flow from operations is up +16.44% year-on-year

    Cash from investing

    -
    ANEB annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    ANEB annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    -$62.40K
    ANEB annual cash flow from financing activities is -$62.40 thousand

    Cash from financing 1-year change

    -100.98%
    ANEB annual cash flow from financing activities is down -100.98% year-on-year

    CAPEX

    CAPEX

    -
    ANEB annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ANEB annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$8.09M
    ANEB annual free cash flow is -$8.09 million

    Free cash flow 1-year change

    +16.44%
    ANEB annual free cash flow is up +16.44% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ANEB annual gross profit margin value is unknown

    Operating margin

    -
    ANEB annual operating profit margin value is unknown

    Net margin

    -
    ANEB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -201.36%
    ANEB annual return on assets is -201.36%

    ROE

    -215.13%
    ANEB annual return on equity is -215.13%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ANEB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ANEB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    9.46
    ANEB price to book ratio is 9.46

    PB ratio Sector rank

    88.5%
    ANEB price to book ratio is higher than 88.5% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ANEB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ANEB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $114.08M
    ANEB enterprise value is $114.08 million

    Enterprise value Sector rank

    45.87%
    ANEB enterprise value is higher than 45.87% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -15.70
    ANEB EV/EBITDA is -15.70

    EV/EBITDA Sector rank

    10.3%
    ANEB EV/EBITDA is higher than 10.3% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    13.46
    ANEB annual current ratio is 13.46

    Quick ratio

    -
    ANEB annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ANEB annual debt to equity ratio is 0.00

    Interest coverage ratio

    -53.24
    ANEB annual interest coverage ratio is -53.24

    Risk & Stability

    Piotroski F-Score

    -
    ANEB piotroski f-score value is unknown

    Altman Z-Score

    -
    ANEB altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 23, 25 Maxim Group
    Hold
    May 15, 25 Maxim Group
    Buy
    Nov 19, 24 Benchmark
    Speculative Buy
    Oct 1, 24 Benchmark
    Speculative Buy
    Oct 3, 23 Benchmark
    Speculative Buy
    Sep 25, 23 HC Wainwright & Co.
    Buy
    Sep 21, 23 Maxim Group
    Buy
    Sep 18, 23 HC Wainwright & Co.
    Buy
    May 18, 23 Benchmark
    Speculative Buy
    Feb 14, 23 Benchmark
    Speculative Buy

    Institutional Ownership

    Screeners with ANEB included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Stocks with high RSI
    • What is the ticker symbol for Anebulo Pharmaceuticals, Inc.?
    • Does Anebulo Pharmaceuticals, Inc. pay dividends?
    • What sector is Anebulo Pharmaceuticals, Inc. in?
    • What industry is Anebulo Pharmaceuticals, Inc. in?
    • What country is Anebulo Pharmaceuticals, Inc. based in?
    • When did Anebulo Pharmaceuticals, Inc. go public?
    • Is Anebulo Pharmaceuticals, Inc. in the S&P 500?
    • Is Anebulo Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Anebulo Pharmaceuticals, Inc. in the Dow Jones?
    • When was Anebulo Pharmaceuticals, Inc.'s last earnings report?
    • When does Anebulo Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Anebulo Pharmaceuticals, Inc.?

    The ticker symbol for Anebulo Pharmaceuticals, Inc. is NASDAQ:ANEB

    Does Anebulo Pharmaceuticals, Inc. pay dividends?

    No, Anebulo Pharmaceuticals, Inc. does not pay dividends

    What sector is Anebulo Pharmaceuticals, Inc. in?

    Anebulo Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Anebulo Pharmaceuticals, Inc. in?

    Anebulo Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Anebulo Pharmaceuticals, Inc. based in?

    Anebulo Pharmaceuticals, Inc. is headquartered in United States

    When did Anebulo Pharmaceuticals, Inc. go public?

    Anebulo Pharmaceuticals, Inc.'s initial public offering (IPO) was on May 7, 2021

    Is Anebulo Pharmaceuticals, Inc. in the S&P 500?

    No, Anebulo Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Anebulo Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Anebulo Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Anebulo Pharmaceuticals, Inc. in the Dow Jones?

    No, Anebulo Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Anebulo Pharmaceuticals, Inc.'s last earnings report?

    Anebulo Pharmaceuticals, Inc.'s most recent earnings report was on May 13, 2025

    When does Anebulo Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Anebulo Pharmaceuticals, Inc. is September 25, 2025
    On this page